HER2-IN-8

• Description :

  HER2-IN-8 is a HER-2 inhibitor extracted from patent WO2021179274A1 compound 107. HER2-IN-8 can be used for the research of cancer and inflammation[1].

• UNSPSC :

  12352005

• Target :

  EGFR

• Type :

  Reference compound

• Related Pathways :

  JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/her2-in-8.html

• Solubility :

  10 mM in DMSO

• Smiles :

  COC1=C(C2=C(N=CN=C2NC3=CC(C)=C(C=C3)OC4=CN5N=CN=C5N=C4)C=N1)O[C@@H]6CCN(CC6(F)F)C

• Molecular Formula :

  C26H25F2N9O3

• Molecular Weight :

  549.53

• References & Citations :

  [1]Zhou D, et, al. ErbB RECEPTOR INHIBITORS AS ANTI-TUMOR AGENTS. WO2021179274A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  ErbB2/HER2

• CAS Number :

  [2704630-49-7]